Home » Newsletters » BioWorld Science

BioWorld Science

April 7, 2008

View Archived Issues

Effects of INO-8875 on atrioventricular nodal conduction shown in rats

Enhanced lipid effects seen with ezetimibe/simvastatin plus niacin in hyperlipidemia

BTG presents an update on the company's clinical development programs

Satoris enters collaboration with Mayo Clinic to validate early Alzheimer's test

Dr. Reddy's signs definitive agreement to acquire portion of Dowpharma Small

EMEA approves Forsteo for treatment of glucocorticoid-induced osteoporosis

FDA approves Rotarix, a pediatric rotavirus vaccine

Recent patents impart novel metabolic drugs

AZD-1480, a novel JAK2 inhibitor profiled at AstraZeneca

Efficacy of radiotherapy enhanced by SPI-1620

GenVec receives USD 600,000 grant from NIH for malaria vaccine program

Recent patents disclose novel therapeutic agents for inflammatory disorders

EntreMed initiates phase I clinical trial of MKC-1 in metastatic solid tumors

Recent patents describe new treatment options for respiratory disorders

Alfacell reports evaluable events from phase IIIb clinical trial of Onconase

Radius completes enrollment in phase II clinical trial of BA-058 for osteoporosis

PharmAthene acquires Avecia's biodefense vaccines business

ActivBiotics sells intellectual property assets for USD 3.5 million

CG Therapeutics and the University of Washington to develop human monoclonal antibodies

Vical receives USD 2.0 million NIH grant for immunotherapeutic herpes DNA vaccine

EMEA grants orphan drug designation to Tengion for Neo-Bladder Augment for spina bifida

Preclinical profile of Merck's novel HCV protease inhibitor reported at the ACS meeting

EpiCept reports positive clinical data from phase I EPC-2407 trial

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.